Principal Material Sciences Engineer
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Principal Material Sciences Engineer to join our Drug Product Process Sciences team. This is a technical services department that deals with a range of scientific, technical, engineering and mathematical needs from the laboratory to the manufacturing floor. In this partially lab-based role you will focus on material science and provide technical support to manufacturing, quality, combination products, formulations, and CMC Regulatory for manufacturing processes from technology transfer and/or design transfer to post-commercial lifecycle management activities.
Job description
When & where
- Location: East Greenbush, New York, United States
- Work model: Monday-Friday, 8am-4:30pm
- Travel percentage: 5% domestic & occasionally international
Discover your role
- Applies materials expertise across polymer science, physics, metallurgy, ceramics, and composites, connecting structure, processing, properties, and performance to drive design, development, and life-cycle management in biomedical or biopharmaceutical environments
- Provides technical support, guidance, and risk assessment related to materials science across technology transfer, design transfer, process control strategy, process validation lifecycle, and post-commercialization activities
- Analyzes data and information—from development through late-stage characterization and at-scale manufacturing history—using statistics, engineering principles, and other techniques to drive insights into process performance and control
- Applies engineering principles to develop and execute process controls and validation strategies, including support for laboratory and at-scale studies for process characterization and validation
- Liaises with cross-functional departments (Combination Products, Manufacturing, Quality Control, Formulation Development, Advanced Therapies, Quality Assurance, and CMC Regulatory) to support process lifecycle management
- Authors protocols, reports, and technical documents with conclusions grounded in process and product knowledge, and ensures SOPs, policies, and validation plans align with industry/regulatory expectations (e.g., ICH guidelines)
- Supports audits/inspections and contributes to CMC sections of regulatory submissions as needed
This role requires
- BS in Materials Science Engineering or related Engineering field and 8+ years of relevant experience
- M.S. or Ph.D. preferred
- A background in aseptic processing, drug substance development, drug product development, combination product development
Requirements
- BS in Materials Science Engineering or related Engineering field
- 8+ years of relevant experience
- Background in aseptic processing
- Background in drug substance development
- Background in drug product development
- Background in combination product development
- M.S. or Ph.D. preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.